 Michael Rizzari
Concepts (188)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 29 | 2026 | 827 | 3.130 |
Why?
| | Organ Preservation | 11 | 2026 | 125 | 1.810 |
Why?
| | End Stage Liver Disease | 7 | 2023 | 95 | 1.470 |
Why?
| | Living Donors | 10 | 2022 | 282 | 1.170 |
Why?
| | Graft Survival | 10 | 2026 | 519 | 0.860 |
Why?
| | Kidney Transplantation | 7 | 2022 | 712 | 0.800 |
Why?
| | Perfusion | 8 | 2026 | 251 | 0.730 |
Why?
| | Liver Circulation | 1 | 2021 | 12 | 0.670 |
Why?
| | Portal Vein | 2 | 2026 | 117 | 0.650 |
Why?
| | Islets of Langerhans Transplantation | 6 | 2016 | 71 | 0.640 |
Why?
| | Tissue and Organ Procurement | 5 | 2025 | 343 | 0.600 |
Why?
| | Lung Transplantation | 1 | 2022 | 332 | 0.560 |
Why?
| | Venous Thrombosis | 1 | 2021 | 196 | 0.560 |
Why?
| | Graft Rejection | 4 | 2017 | 521 | 0.510 |
Why?
| | Liver | 9 | 2025 | 1899 | 0.480 |
Why?
| | Postoperative Complications | 7 | 2019 | 2977 | 0.430 |
Why?
| | Hepatitis C, Chronic | 3 | 2022 | 153 | 0.420 |
Why?
| | Prednisone | 2 | 2013 | 226 | 0.410 |
Why?
| | Microspheres | 2 | 2011 | 142 | 0.400 |
Why?
| | Reperfusion Injury | 2 | 2026 | 292 | 0.370 |
Why?
| | Renal Artery | 2 | 2011 | 43 | 0.360 |
Why?
| | Histocompatibility Testing | 1 | 2011 | 123 | 0.340 |
Why?
| | Tissue Donors | 4 | 2025 | 420 | 0.330 |
Why?
| | Donor Selection | 1 | 2011 | 79 | 0.320 |
Why?
| | Nephrectomy | 1 | 2011 | 163 | 0.320 |
Why?
| | Immunosuppressive Agents | 2 | 2013 | 838 | 0.320 |
Why?
| | Hepatitis C | 3 | 2022 | 256 | 0.300 |
Why?
| | Kidney | 4 | 2021 | 1497 | 0.280 |
Why?
| | Islets of Langerhans | 6 | 2016 | 847 | 0.270 |
Why?
| | Swine | 9 | 2025 | 826 | 0.270 |
Why?
| | Risk Factors | 13 | 2025 | 10919 | 0.260 |
Why?
| | Waiting Lists | 7 | 2023 | 266 | 0.250 |
Why?
| | Non-alcoholic Fatty Liver Disease | 2 | 2020 | 265 | 0.240 |
Why?
| | Thrombocytopenia | 2 | 2017 | 204 | 0.220 |
Why?
| | Adult | 23 | 2026 | 40881 | 0.220 |
Why?
| | Hypothermia, Induced | 1 | 2026 | 96 | 0.220 |
Why?
| | Pancreas | 3 | 2014 | 341 | 0.220 |
Why?
| | Hyperkalemia | 1 | 2025 | 36 | 0.210 |
Why?
| | Cold Ischemia | 2 | 2022 | 40 | 0.210 |
Why?
| | Intraoperative Complications | 1 | 2025 | 157 | 0.200 |
Why?
| | Humans | 40 | 2026 | 145783 | 0.190 |
Why?
| | Transplantation, Heterologous | 2 | 2014 | 170 | 0.180 |
Why?
| | Retrospective Studies | 14 | 2022 | 17330 | 0.180 |
Why?
| | Transplants | 1 | 2022 | 38 | 0.180 |
Why?
| | Treatment Outcome | 8 | 2021 | 11794 | 0.180 |
Why?
| | Carcinoma, Hepatocellular | 2 | 2022 | 373 | 0.170 |
Why?
| | Death | 3 | 2022 | 132 | 0.170 |
Why?
| | Hyponatremia | 1 | 2021 | 43 | 0.170 |
Why?
| | Sodium | 2 | 2021 | 198 | 0.170 |
Why?
| | Severity of Illness Index | 4 | 2021 | 2933 | 0.160 |
Why?
| | Middle Aged | 14 | 2026 | 36309 | 0.160 |
Why?
| | Coinfection | 1 | 2022 | 143 | 0.160 |
Why?
| | Hepatitis, Alcoholic | 1 | 2020 | 16 | 0.160 |
Why?
| | Time Factors | 5 | 2021 | 7134 | 0.150 |
Why?
| | Liver Regeneration | 1 | 2019 | 46 | 0.150 |
Why?
| | Blood Flow Velocity | 1 | 2021 | 421 | 0.150 |
Why?
| | Graft vs Host Disease | 1 | 2021 | 279 | 0.140 |
Why?
| | Antiviral Agents | 3 | 2022 | 769 | 0.140 |
Why?
| | Kaplan-Meier Estimate | 2 | 2012 | 971 | 0.140 |
Why?
| | Liver Neoplasms | 2 | 2022 | 777 | 0.140 |
Why?
| | Cholestasis | 1 | 2021 | 214 | 0.140 |
Why?
| | Male | 18 | 2026 | 73011 | 0.140 |
Why?
| | Liver Diseases, Alcoholic | 1 | 2019 | 98 | 0.130 |
Why?
| | Adenoviridae Infections | 1 | 2018 | 20 | 0.130 |
Why?
| | Cytosine | 1 | 2018 | 49 | 0.130 |
Why?
| | Follow-Up Studies | 5 | 2019 | 5428 | 0.130 |
Why?
| | Female | 19 | 2026 | 79045 | 0.130 |
Why?
| | Tissue and Organ Harvesting | 1 | 2018 | 78 | 0.130 |
Why?
| | Bile Duct Diseases | 1 | 2017 | 13 | 0.130 |
Why?
| | Organophosphonates | 1 | 2018 | 95 | 0.130 |
Why?
| | Survival Rate | 4 | 2019 | 2094 | 0.130 |
Why?
| | Policy | 3 | 2023 | 149 | 0.120 |
Why?
| | Liver Cirrhosis | 1 | 2019 | 288 | 0.120 |
Why?
| | Magnets | 1 | 2016 | 21 | 0.120 |
Why?
| | Prognosis | 5 | 2022 | 4330 | 0.120 |
Why?
| | Immunocompromised Host | 1 | 2018 | 202 | 0.120 |
Why?
| | Mortality | 1 | 2019 | 381 | 0.120 |
Why?
| | Transplant Recipients | 1 | 2018 | 182 | 0.120 |
Why?
| | Hepatectomy | 1 | 2018 | 274 | 0.110 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2021 | 699 | 0.110 |
Why?
| | Research Design | 1 | 2021 | 1139 | 0.110 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2021 | 1752 | 0.100 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2021 | 668 | 0.100 |
Why?
| | Hypertension | 2 | 2013 | 1276 | 0.100 |
Why?
| | Glomerular Filtration Rate | 2 | 2019 | 765 | 0.090 |
Why?
| | Heart | 2 | 2013 | 626 | 0.090 |
Why?
| | Aged | 5 | 2022 | 26217 | 0.090 |
Why?
| | Minnesota | 1 | 2012 | 168 | 0.080 |
Why?
| | Proteinuria | 1 | 2011 | 104 | 0.080 |
Why?
| | Kidney Function Tests | 1 | 2011 | 156 | 0.080 |
Why?
| | Delayed Graft Function | 1 | 2011 | 46 | 0.080 |
Why?
| | Animals | 12 | 2025 | 38102 | 0.080 |
Why?
| | Young Adult | 4 | 2021 | 14254 | 0.080 |
Why?
| | Oxygen Consumption | 2 | 2010 | 719 | 0.080 |
Why?
| | Pancreas Transplantation | 1 | 2010 | 71 | 0.080 |
Why?
| | Oxygen | 2 | 2013 | 981 | 0.080 |
Why?
| | Drug Administration Schedule | 1 | 2012 | 782 | 0.080 |
Why?
| | Creatinine | 1 | 2011 | 515 | 0.070 |
Why?
| | Hepacivirus | 2 | 2022 | 242 | 0.070 |
Why?
| | Renal Insufficiency | 1 | 2011 | 172 | 0.070 |
Why?
| | Kidney Diseases | 1 | 2013 | 426 | 0.070 |
Why?
| | Age Factors | 2 | 2019 | 3346 | 0.070 |
Why?
| | Multivariate Analysis | 1 | 2011 | 1547 | 0.070 |
Why?
| | Mycophenolic Acid | 2 | 2021 | 119 | 0.060 |
Why?
| | Platelet Count | 2 | 2017 | 94 | 0.060 |
Why?
| | HIV Infections | 1 | 2022 | 3195 | 0.060 |
Why?
| | Proportional Hazards Models | 2 | 2019 | 1330 | 0.060 |
Why?
| | Energy Metabolism | 1 | 2012 | 935 | 0.060 |
Why?
| | Potassium | 1 | 2025 | 152 | 0.050 |
Why?
| | Models, Animal | 1 | 2024 | 392 | 0.050 |
Why?
| | United States | 4 | 2022 | 16126 | 0.050 |
Why?
| | Weather | 1 | 2022 | 43 | 0.050 |
Why?
| | Registries | 2 | 2022 | 2410 | 0.040 |
Why?
| | Risk Assessment | 1 | 2012 | 3752 | 0.040 |
Why?
| | Cold Temperature | 2 | 2014 | 206 | 0.040 |
Why?
| | Warm Ischemia | 1 | 2021 | 19 | 0.040 |
Why?
| | Anesthesia | 1 | 2025 | 257 | 0.040 |
Why?
| | Heart Arrest | 1 | 2025 | 411 | 0.040 |
Why?
| | Endpoint Determination | 1 | 2021 | 85 | 0.040 |
Why?
| | Cohort Studies | 1 | 2011 | 6033 | 0.040 |
Why?
| | Organ Preservation Solutions | 2 | 2010 | 46 | 0.040 |
Why?
| | Karnofsky Performance Status | 1 | 2019 | 37 | 0.040 |
Why?
| | Liver Failure | 1 | 2019 | 83 | 0.040 |
Why?
| | Consensus | 1 | 2021 | 479 | 0.040 |
Why?
| | Cerebrovascular Disorders | 1 | 2019 | 105 | 0.030 |
Why?
| | Abdominal Wall | 1 | 2018 | 28 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 1 | 2010 | 3916 | 0.030 |
Why?
| | Waist Circumference | 1 | 2018 | 143 | 0.030 |
Why?
| | Operative Time | 1 | 2018 | 181 | 0.030 |
Why?
| | Reoperation | 1 | 2020 | 637 | 0.030 |
Why?
| | Renal Dialysis | 1 | 2021 | 466 | 0.030 |
Why?
| | Centrifugation, Density Gradient | 1 | 2016 | 36 | 0.030 |
Why?
| | Salvage Therapy | 1 | 2018 | 165 | 0.030 |
Why?
| | Cause of Death | 1 | 2019 | 472 | 0.030 |
Why?
| | Constriction, Pathologic | 1 | 2017 | 249 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2022 | 1150 | 0.030 |
Why?
| | Heart Transplantation | 2 | 2013 | 680 | 0.030 |
Why?
| | Hospitals, High-Volume | 1 | 2016 | 50 | 0.030 |
Why?
| | Life Support Care | 1 | 2016 | 42 | 0.030 |
Why?
| | Withholding Treatment | 1 | 2016 | 80 | 0.030 |
Why?
| | Incidence | 1 | 2021 | 2934 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2018 | 1115 | 0.020 |
Why?
| | Laparoscopy | 1 | 2018 | 481 | 0.020 |
Why?
| | Cell Separation | 1 | 2014 | 306 | 0.020 |
Why?
| | History, 21st Century | 1 | 2013 | 222 | 0.020 |
Why?
| | Steroids | 1 | 2013 | 160 | 0.020 |
Why?
| | Cell Transplantation | 1 | 2012 | 39 | 0.020 |
Why?
| | Reperfusion | 1 | 2012 | 54 | 0.020 |
Why?
| | Length of Stay | 1 | 2018 | 1350 | 0.020 |
Why?
| | Cyclosporine | 1 | 2013 | 256 | 0.020 |
Why?
| | History, 20th Century | 1 | 2013 | 328 | 0.020 |
Why?
| | Tacrolimus | 1 | 2013 | 196 | 0.020 |
Why?
| | Acute Kidney Injury | 1 | 2019 | 874 | 0.020 |
Why?
| | Transplantation, Homologous | 1 | 2013 | 419 | 0.020 |
Why?
| | Magnetic Phenomena | 1 | 2011 | 10 | 0.020 |
Why?
| | Sirolimus | 1 | 2013 | 282 | 0.020 |
Why?
| | Cryopreservation | 1 | 2012 | 113 | 0.020 |
Why?
| | Euthanasia | 1 | 2010 | 3 | 0.020 |
Why?
| | Coculture Techniques | 1 | 2011 | 247 | 0.020 |
Why?
| | Renal Veins | 1 | 2010 | 18 | 0.020 |
Why?
| | Blood Substitutes | 1 | 2010 | 27 | 0.020 |
Why?
| | Mesenteric Artery, Superior | 1 | 2010 | 28 | 0.020 |
Why?
| | Formaldehyde | 1 | 2010 | 65 | 0.020 |
Why?
| | Diabetes Mellitus, Type 1 | 3 | 2013 | 3937 | 0.020 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2011 | 199 | 0.020 |
Why?
| | Materials Testing | 1 | 2011 | 345 | 0.020 |
Why?
| | Mice, Nude | 1 | 2011 | 680 | 0.020 |
Why?
| | Adenosine Triphosphate | 1 | 2012 | 500 | 0.020 |
Why?
| | Capillaries | 1 | 2010 | 125 | 0.020 |
Why?
| | Body Mass Index | 1 | 2018 | 2447 | 0.020 |
Why?
| | Antihypertensive Agents | 1 | 2013 | 521 | 0.020 |
Why?
| | Fluorocarbons | 1 | 2010 | 120 | 0.020 |
Why?
| | Cell Death | 1 | 2010 | 382 | 0.020 |
Why?
| | Magnetic Resonance Angiography | 1 | 2010 | 251 | 0.020 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2010 | 627 | 0.020 |
Why?
| | Aorta | 1 | 2010 | 441 | 0.020 |
Why?
| | Cell Survival | 1 | 2010 | 1104 | 0.020 |
Why?
| | Cardiovascular Diseases | 1 | 2019 | 2191 | 0.020 |
Why?
| | Adolescent | 2 | 2017 | 22577 | 0.010 |
Why?
| | Anticoagulants | 1 | 2010 | 748 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2011 | 4151 | 0.010 |
Why?
| | Rats | 1 | 2010 | 5585 | 0.010 |
Why?
| | Prospective Studies | 1 | 2013 | 8078 | 0.010 |
Why?
| | Insulin | 1 | 2011 | 2516 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2011 | 5993 | 0.010 |
Why?
| | Child, Preschool | 1 | 2013 | 11868 | 0.010 |
Why?
| | Mice | 1 | 2011 | 18356 | 0.010 |
Why?
| | Child | 1 | 2013 | 22740 | 0.010 |
Why?
|
|
Rizzari's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|